Iluria

Biomarker-based ADHD Monitoring

Health Tech & Life Sciences
Active
Seed Hod HaSharon Founded 2018
Total raised
$2.0M
Last: Seed 2021-06
Stage
Seed
Founded
2018
Headcount
21
HQ
Hod HaSharon
Sector
Health Tech & Life Sciences

About

Iluria is a clinically proven software solution that provides in-depth continuous and passive monitoring using any commercial smart wearable. By detecting any patterns related to ADHD, Iluria can shed light on the effectiveness of treatment, enabling those who suffer from ADHD to receive personalized and accurate care quickly and without guesswork. Iluria can provide parents with peace of mind knowing that their ADHD children are living healthy, happy lives. Iluria has completed two successful clinical trials with the Cincinnati Childrens Hospital Medical Center and Clalit Health Services (the worlds second-largest HMO, serving close to 5 million patients).

Funding history · 3 rounds · $2.0M total

2021-06
Seed Undisclosed
2020-12
Pre-Seed $125K
2020-10
Equity crowdfunding $1.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyChildrenParents
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

data-analyticsmental-healthwellnessdata-analyticsmhealthpharma-companieswell-beinghealthcare-providersclinicsmedical-technologiesmonitoringweb-platformparentsdoctorsreal-timemachine-learningdeep-learningdigital-healthcaremobile-applicationswearablepersonalizationartificial-intelligencedecision-supportchildren